Literature DB >> 23149894

Functional imaging in adult and paediatric brain tumours.

Andrew C Peet1, Theodoros N Arvanitis, Martin O Leach, Adam D Waldman.   

Abstract

Imaging is a key component in the management of brain tumours, with MRI being the preferred modality for most clinical scenarios. However, although conventional MRI provides mainly structural information, such as tumour size and location, it leaves many important clinical questions, such as tumour type, aggressiveness and prognosis, unanswered. An increasing number of studies have shown that additional information can be obtained using functional imaging methods (which probe tissue properties), and that these techniques can give key information of clinical importance. These techniques include diffusion imaging, which can assess tissue structure, and perfusion imaging and magnetic resonance spectroscopy, which measures tissue metabolite profiles. Tumour metabolism can also be investigated using PET, with 18F-deoxyglucose being the most readily available tracer. This Review discusses these methods and the studies that have investigated their clinical use. A strong emphasis is placed on the measurement of quantitative parameters, which is a move away from the qualitative nature of conventional radiological reporting and presents major challenges, particularly for multicentre studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149894     DOI: 10.1038/nrclinonc.2012.187

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  110 in total

1.  Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Martin Krssak; Georgi Minchev; Adelheid Wöhrer; Tatjana Traub-Weidinger; Thomas Czech; Susanne Asenbaum; Christine Marosi; Engelbert Knosp; Johannes A Hainfellner; Daniela Prayer; Stefan Wolfsberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-22       Impact factor: 10.154

2.  Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Authors:  Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

3.  Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.

Authors:  Shuichi Higano; Xia Yun; Toshihiro Kumabe; Mika Watanabe; Shunji Mugikura; Atsushi Umetsu; Akihiro Sato; Takayuki Yamada; Shoki Takahashi
Journal:  Radiology       Date:  2006-10-10       Impact factor: 11.105

Review 4.  Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Authors:  Dieta Brandsma; Lukas Stalpers; Walter Taal; Peter Sminia; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

5.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

6.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Authors:  Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

7.  Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Authors:  Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105

8.  Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma.

Authors:  Darren Hargrave; Nathaniel Chuang; Eric Bouffet
Journal:  J Neurooncol       Date:  2007-10-02       Impact factor: 4.130

9.  Preoperative functional magnetic resonance imaging assessment of higher-order cognitive function in patients undergoing surgery for brain tumors.

Authors:  Céline Amiez; Penelope Kostopoulos; Anne-Sophie Champod; D Louis Collins; Julien Doyon; Rolando Del Maestro; Michael Petrides
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

10.  Validity of primary motor area localization with fMRI versus electric cortical stimulation: a comparative study.

Authors:  Robert Bartos; Robert Jech; Josef Vymazal; Pavel Petrovický; Petr Vachata; Ales Hejcl; Amir Zolal; Martin Sames
Journal:  Acta Neurochir (Wien)       Date:  2009-05-05       Impact factor: 2.216

View more
  28 in total

Review 1.  European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.

Authors:  Shivaram Avula; Andrew Peet; Giovanni Morana; Paul Morgan; Monika Warmuth-Metz; Tim Jaspan
Journal:  Childs Nerv Syst       Date:  2021-05-10       Impact factor: 1.475

2.  Management of high-grade gliomas in the pediatric patient: Past, present, and future.

Authors:  Magimairajan Issai Vanan; David D Eisenstat
Journal:  Neurooncol Pract       Date:  2014-09-12

3.  Local morphology predicts functional organization of experienced value signals in the human orbitofrontal cortex.

Authors:  Yansong Li; Guillaume Sescousse; Céline Amiez; Jean-Claude Dreher
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 4.  Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors.

Authors:  Rebecca W Pak; Darian H Hadjiabadi; Janaka Senarathna; Shruti Agarwal; Nitish V Thakor; Jay J Pillai; Arvind P Pathak
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

5.  (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.

Authors:  Chunjing Yu; Donghui Pan; Baoming Mi; Yuping Xu; Lixin Lang; Gang Niu; Min Yang; Weixing Wan; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-01       Impact factor: 9.236

6.  Color-coded digital subtraction angiography in the management of a rare case of middle cerebral artery pure arterial malformation. A technical and case report.

Authors:  Caleb E Feliciano; Eva Pamias-Portalatin; Jorge Mendoza-Torres; Euclides Effio; Yadira Moran; Rafael Rodriguez-Mercado
Journal:  Interv Neuroradiol       Date:  2014-12-05       Impact factor: 1.610

7.  Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Authors:  Giovanni Morana; Arnoldo Piccardo; Matteo Puntoni; Paolo Nozza; Armando Cama; Alessandro Raso; Samantha Mascelli; Michela Massollo; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi
Journal:  Neuro Oncol       Date:  2015-09-23       Impact factor: 12.300

8.  Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.

Authors:  Constantin Roder; Marco Skardelly; Kristofer Fingerle Ramina; Rudi Beschorner; Jürgen Honneger; Thomas Nägele; Marcos Soares Tatagiba; Ulrike Ernemann; Sotirios Bisdas
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-10-20       Impact factor: 2.924

Review 9.  Engineering and physical sciences in oncology: challenges and opportunities.

Authors:  Michael J Mitchell; Rakesh K Jain; Robert Langer
Journal:  Nat Rev Cancer       Date:  2017-10-13       Impact factor: 60.716

10.  Advanced neuroimaging in the clinic: critical appraisal of the evidence base.

Authors:  Adam Z Fink; Lisa B Mogil; Michael L Lipton
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.